000 01670 a2200445 4500
005 20250512201403.0
264 0 _c19820826
008 198208s 0 0 eng d
022 _a0004-8291
024 7 _a10.1111/j.1445-5994.1982.tb02447.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLevi, J A
245 0 0 _aSignificant factors in the optimal management of advanced stage germ cell carcinoma.
_h[electronic resource]
260 _bAustralian and New Zealand journal of medicine
_cApr 1982
300 _a147-52 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBleomycin
_xadministration & dosage
650 0 4 _aChoriocarcinoma
_xdrug therapy
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aDactinomycin
_xadministration & dosage
650 0 4 _aDrug Evaluation
650 0 4 _aDrug Therapy, Combination
650 0 4 _aDysgerminoma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLeukopenia
_xchemically induced
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aRetroperitoneal Neoplasms
_xdrug therapy
650 0 4 _aSepsis
_xchemically induced
650 0 4 _aTeratoma
_xdrug therapy
650 0 4 _aTesticular Neoplasms
_xdrug therapy
650 0 4 _aVinblastine
_xadministration & dosage
700 1 _aAroney, R S
700 1 _aDalley, D N
773 0 _tAustralian and New Zealand journal of medicine
_gvol. 12
_gno. 2
_gp. 147-52
856 4 0 _uhttps://doi.org/10.1111/j.1445-5994.1982.tb02447.x
_zAvailable from publisher's website
999 _c6178438
_d6178438